Bond Oracle HER2 IHC System Fully Automated
The Bond Oracle HER2 IHC System is a fully-automated assay to accurately determine HER2 oncoprotein status in breast cancer tissue as an aid in the assessment of patients for whom Herceptin® (trastuzumab) treatment is being considered.
- Accurate - optimized to precisely separate 1+ and 2+ cases gives you excellent FISH concordance, reducing avoidable FISH requests.
- Drive Consistency - standardized protocols for uniform staining, decreased process variation, and consistent results.
- Maximize Efficiency - full automation frees up your skilled staff for other high-value tasks.
- A Complete Solution - integrated ready-to-use reagents, control slides, and advanced automation ensure quality and consistency.
For In Vitro Diagnostics Use